Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insufficient Physical Activity”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Large-scale testing (Phase 3)Study completedNCT01063062
What this trial is testing

A Study With Tocilizumab [RoActemra/Actemra] Monotherapy or in Combination With Methotrexate in Patients With Rheumatoid Arthritis (PICTURE)

Who this might be right for
Rheumatoid Arthritis
Hoffmann-La Roche 107
Testing effectiveness (Phase 2)Study completedNCT05666128
What this trial is testing

Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Hyundai Pharm 112
Large-scale testing (Phase 3)Ended earlyNCT03760965
What this trial is testing

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus
Sanofi 276
Post-approval studies (Phase 4)Study completedNCT01717222
What this trial is testing

Effect of Intraperitoneal and Intravenous Lignocaine on Pain Relief Following Laparoscopic Cholecystectomy

Who this might be right for
Pain, PostoperativeAnalgesic RequirementStress Response+2 more
Jawaharlal Institute of Postgraduate Medical Education & Research 50
Post-approval studies (Phase 4)Study completedNCT01864174
What this trial is testing

Phase 4: Investigational Study to Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 1,736
Testing effectiveness (Phase 2)Looking for participantsNCT06846320
What this trial is testing

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
AbbVie 315
Large-scale testing (Phase 3)Study completedNCT01177813
What this trial is testing

Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 986
Testing effectiveness (Phase 2)Looking for participantsNCT06647550
What this trial is testing

To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm 160
Large-scale testing (Phase 3)Study completedNCT01958671
What this trial is testing

The Efficacy and Safety of Ertugliflozin Monotherapy in the Treatment of Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control Despite Diet and Exercise (MK-8835-003, VERTIS MONO)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 461
Large-scale testing (Phase 3)Study completedNCT01545388
What this trial is testing

Metformin Add-on Regimen Comparison Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431A-136)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 337
Large-scale testing (Phase 3)Study completedNCT02324569
What this trial is testing

A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Takeda 240
Testing effectiveness (Phase 2)Study completedNCT01046422
What this trial is testing

Safety Study of BMS-770767 in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Type 2
Bristol-Myers Squibb 76
Large-scale testing (Phase 3)Study completedNCT02721966
What this trial is testing

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement

Who this might be right for
Axial Psoratic Arthritis
Novartis Pharmaceuticals 503
Large-scale testing (Phase 3)Looking for participantsNCT07743983
What this trial is testing

BGM0504 in Early T2DM With Obesity

Who this might be right for
Type 2 Diabetes (T2DM)
BrightGene Bio-Medical Technology Co., Ltd. 372
Post-approval studies (Phase 4)Study completedNCT00832390
What this trial is testing

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

Who this might be right for
Diabetes Mellitus
Merck Sharp & Dohme LLC 29
Post-approval studies (Phase 4)Study completedNCT01686711
What this trial is testing

A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322

Who this might be right for
Diabetes Mellitus
Takeda 207
Testing effectiveness (Phase 2)Study completedNCT03645421
What this trial is testing

Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
AstraZeneca 61
Large-scale testing (Phase 3)Study completedNCT00698932
What this trial is testing

Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control

Who this might be right for
Type 2 Diabetes
AstraZeneca 568
Testing effectiveness (Phase 2)Study completedNCT02014363
What this trial is testing

Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
e-Therapeutics PLC 164
Testing effectiveness (Phase 2)Study completedNCT03637556
What this trial is testing

Pilot Study to Assess the Safety, PK and Iron Chelating Activity of DST-0509 (Deferasirox) in Thalassemia Patients Refractory to Chelation

Who this might be right for
Thalassemia Major
DisperSol Technologies, LLC 25
Next Page